跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
YL-231
首页
药物
YL-231
YL-231
未知生产厂商
订阅
生成 AI 研报
Share to Twitter
Share to Facebook
Share to LinkedIn
Share to Reddit
摘要
临床试验
审批记录
专利
每项发明一条,涵盖美国、欧洲、PCT 与中国的同族专利。
Application of Chukrasone B in medicine for treating breast cancer
CN 103405418 A
申请人: NANJING UNIVERSITY OF TECHNOLOGY
优先权: 2013
CN
Application of Chukrasone A in medicaments for treating breast carcinoma
CN 103405449 A
申请人: NANJING UNIVERSITY OF TECHNOLOGY
优先权: 2013
CN
New crystal form of compound and preparation method and application thereof
CN 106831608 A
申请人: JIANGSU AIDEA PHARMACEUTICAL CO LTD
优先权: 2017
CN
3-(thiazole-4-yl methyl alkene) indoline-2-ketone compound with triple negative breast cancer resisting activity, preparation method and application of 3-(thiazole-4-yl methyl alkene) indoline-2-ketone compound
CN 119707951 A
申请人: UNIV SHENZHEN
优先权: 2023
CN
Ester compound, diaryl acrylic acid mixture and preparation method and application thereof
CN 117924231 A
申请人: UNIV PUTIAN
优先权: 2023
CN
Deuterated 2-(azetidine-3-yl) ethanone compound as well as pharmaceutical composition and application thereof
CN 120309609 A
申请人: YICHANG HUMANWELL PHARMACEUTICAL CO LTD
优先权: 2024
CN
一种姜黄类似物、制备方法及其应用
CN 120887869 B
申请人: 陕西省生物农业研究所
优先权: 2025
CN
药物
反馈